PLGA in situ implants formed by phase inversion: Critical physicochemical parameters to modulate drug release
- 1 November 2013
- journal article
- review article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 172 (1), 292-304
- https://doi.org/10.1016/j.jconrel.2013.08.024
Abstract
No abstract availableKeywords
Funding Information
- Agence Nationale de la Recherche
This publication has 103 references indexed in Scilit:
- Improved physical stability and injectability of non-aqueous in situ PLGA microparticle forming emulsionsInternational Journal of Pharmaceutics, 2012
- Formulation and evaluation of in situ forming PLA implant containing tinidazole for the treatment of periodontitisJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2012
- Noninvasive Characterization of the Effect of Varying PLGA Molecular Weight Blends on In Situ Forming Implant Behavior Using Ultrasound ImagingTheranostics, 2012
- A novel injectablein situforming poly-DL-lactide and DL-lactide/glycolide implant containing lipospheres for controlled drug deliveryJournal of Liposome Research, 2011
- Effect of injection site on in situ implant formation and drug release in vivoJournal of Controlled Release, 2010
- Noninvasive characterization of in situ forming implants using diagnostic ultrasoundJournal of Controlled Release, 2010
- Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systemsJournal of Biomedical Materials Research Part A, 2010
- Current advances in research and clinical applications of PLGA-based nanotechnologyExpert Review of Molecular Diagnostics, 2009
- Formulation and Evaluation of PLA and PLGA In Situ Implants Containing Secnidazole and/or Doxycycline for Treatment of PeriodontitisAAPS PharmSciTech, 2008
- Effect of excipients on PLGA film degradation and the stability of an incorporated peptideJournal of Controlled Release, 2007